Despite considerable progress in the discovery and development of new cancer drugs between 1990 and 2022, there may be disparities in both the availability and timeliness of these treatment options gl…
Early Career Award | Cancer Discovery | American Association for Cancer Research .aacrcontent .banner{ width: 100% margin: -20px; } .aacrcontent .banner-sm{ display: none; } .right{float:…
Join MD Anderson to help dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce the devastating effects of cancer.
The Cancer Today editors share the most impactful reporting on cancer research from 2024.
A panel of experts on multiple myeloma discuss the role of CAR T-cell therapy in the evolving treatment landscape, highlighting clinical trial data, recent approvals,…
Stacey A. Cohen, MD, discusses insights into the evolving role of circulating tumor DNA in clinical decision-making for patients with colorectal cancer.
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase…
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection
Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, according to 6-year data from the OlympiA…
With the close of 2024, we wanted to take stock of the eighth year for Blood Advances, which had another banner year. We continue to…
